NEW YORK, Nov. 9, 2016 /PRNewswire/ -- As Nexium lawsuits and other kidney injury claims involving proton pump inhibitors continue to mount in courts around the U.S., parties to those cases have been given additional time to respond to a motion seeking the centralization of all such federal claims in a single U.S. District Court. According to a docket entry posted on November 7th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), responses are now due on or before November 17, 2016.
"Our Firm is representing plaintiffs in Nexium lawsuits involving chronic kidney disease and other renal complications that are now pending in federal court. We will continue to monitor the nationwide litigation closely, and look forward to the JPML's decision regarding the possible consolidation of these cases," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP. The Firm is now offering free legal reviews to individuals who were diagnosed with chronic kidney disease, kidney failure, acute kidney injury, or acute interstitial nephritis following extended use of prescription or over-the-counter proton pump inhibitors.
Proton Pump Inhibitor Lawsuits
According to a Motion for Transfer filed with the JPML on October 17th, there were at least 15 proton pump inhibitor lawsuits pending in courts around the country. Since then, additional claims have been filed against the manufactures of PrevAcid, Prilosec and Nexium on behalf of plaintiffs who allegedly developed chronic kidney disease, acute interstitial nephritis, renal failure and other kidney complications due to their use of the popular heartburn medications. Plaintiffs who filed the Motion for Transfer asserted that hundreds of such claims could eventually be filed, and have proposed that the growing federal litigation be consolidated in the U.S. District Court, Middle District of Louisiana.
The creation of a multidistrict litigation for federal proton pump inhibitor lawsuits would allow these claims, as well as any filed in the future, to undergo coordinated pretrial proceedings, including motion practice and discovery. As such, centralization of these cases would preserve the resources of the courts, parties and witness involved in the litigation.
Individuals who were diagnosed with serious kidney complications following treatment with Nexium or another proton pump inhibitor may be entitled to compensation for medical bills, lost wages, pain and suffering, and any other injury-related damages they incurred. To learn more about filing a proton pump inhibitor lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nexium-lawsuit-update-responses-to-proposed-multidistrict-litigation-due-on-november-17th-bernstein-liebhard-llp-reports-300359834.html
SOURCE Bernstein Liebhard LLP